Dengue IgM antibodies (DENV IgM) were detected using ELISA (NIV, Pune) if presentation was more than 3–5 days after the onset of clinical symptoms and/or NS1 antigen assay (Pan Bio, Queensland, Australia) if the presentation was within 3–5 days after the onset of clinical symptoms. Complete blood counts were analysed in the Institute’s emergency laboratory equipped with a Sysmex KX-21N automated hematology analyser from Sysmex Corporation, Kobe, Japan, which has a daily quality control check by the laboratory. Transaminases, serum urea and creatinine were analysed in the Institute’s central laboratory equipped with a Cobas 8000 analyser from Roche Hitachi Corporation, Japan.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.